RESUMEN
Although the influence of diabetes on salivary glands is well studied, it still presents conflicting results. In this work, the regulation of the phosphofructokinase-1 enzyme (PFK-1) was studied utilizing the salivary glands of rats. Diabetes was induced by a single intraperitoneal injection of streptozotocin (60 mg/Kg of body weight) in rats (180-200 g). The animals were killed 30 days after the induction of diabetes and the submandibular and parotid salivary glands were used. Hyperglycemia was evaluated by blood sugar determination. The distribution of PFK-1 between the soluble and cytoskeleton fractions, the phosphate content of PFK-1, the content of fructose-2,6-bisphosphate and the activity of the PFK-2 enzyme were determined. The calculated relative glandular weight showed a higher value for the parotid gland in comparison with the control, but not for the submandibular gland. The activity of PFK-1 expressed per gland showed no variation between diabetic and control animals. However, considering the specific activity, the soluble enzyme presented a value 50% higher than that of the control and the cytoskeleton bound form increased by 84% compared to the control. For the parotid gland, no difference in the specific activity between diabetic and control animals was observed. On the other hand, the activity per gland of the soluble enzyme increased in the diabetic animals. The phosphate content of PFK-1 increased in the submandibular and parotid glands of diabetic rats. Both the content of fructose-2,6-bisphosphate and the active form of PFK-2 were reduced in the diabetic glands. In conclusion, the increase in the activity of PFK-1 observed in the salivary glands of rats with streptozotocin-induced diabetes does not seem to be due to its modulator fructose-2,6-bisphosphate.
Asunto(s)
Diabetes Mellitus Experimental/enzimología , Fosfofructoquinasa-1/metabolismo , Glándulas Salivales/enzimología , Animales , Citoesqueleto/enzimología , Diabetes Mellitus Experimental/inducido químicamente , Masculino , Glándula Parótida/enzimología , Fosfofructoquinasa-1/análisis , Ratas , Ratas Wistar , Estreptozocina , Glándula Submandibular/enzimologíaRESUMEN
Apesar de existirem muitos estudos sobre a influência do diabetes nas glândulas salivares, esses apresentam resultados conflitantes. Neste estudo, a regulação da enzima fosfofrutoquinase-1 (PFK-1) foi estudada utilizando-se glândulas salivares de ratos. O diabetes foi induzido por uma única injeção intraperitonial de estreptozotocina (60 mg/kg peso corporal) em ratos (180-200 g). Os animais foram sacrificados 30 dias após a indução do diabetes e utilizaram-se as glândulas submandibular e parótida. A hiperglicemia foi avaliada por determinação da glicemia sanguínea. A distribuição da PFK-1 entre frações solúvel e ligada, concentração de fosfato na PFK-1, concentração de frutose-2,6-bisfosfato e a atividade da enzima PFK-2 foram determinadas. O cálculo do peso glandular relativo mostrou um aumento na glândula parótida de ratos diabéticos comparados ao controle, o que não ocorreu na glândula submandibular. A atividade da PFK-1 expressa por glândula não mostrou variação entre animais diabético e controle. Contudo, considerando a atividade específica, a fração solúvel da enzima mostrou aumento de 50% com relação ao controle e a fração ligada ao citoesqueleto um aumento de 84% com relação ao controle. Na glândula parótida não foi observada diferença na atividade específica entre os grupos diabético e controle. Por outro lado, a atividade por glândula da fração solúvel aumentou nos animais diabéticos. A concentração de fosfato da PFK-1 aumentou nas glândulas submandibular e parótida nos animais diabéticos. Tanto a concentração de frutose-2,6-bisfosfato quanto a forma ativa da PFK-2 mostraram redução nas glândulas salivares. Concluindo, o aumento na atividade da PFK-1 observado nas glândulas salivares de ratos com diabetes induzida por estreptozotocina não parece ser modulado pela frutose-2,6-bisfosfato.
Asunto(s)
Animales , Masculino , Ratas , Diabetes Mellitus Experimental/enzimología , Fosfofructoquinasa-1/metabolismo , Glándulas Salivales/enzimología , Citoesqueleto/enzimología , Diabetes Mellitus Experimental/inducido químicamente , Glándula Parótida/enzimología , Fosfofructoquinasa-1/análisis , Ratas Wistar , Estreptozocina , Glándula Submandibular/enzimologíaRESUMEN
Phosphofructokinase-1 plays a key role in the regulation of carbohydrate metabolism. Its activity can be used as an indicator of the glycolytic flux in a tissue sample. The method most commonly employed to determine phosphofructokinase-1 activity is based on oxidation of NADH by the use of aldolase, triosephosphate isomerase, and alpha-glycerophosphate dehydrogenase. This method suffers from several disadvantages, including interactions of the auxiliary enzymes with phosphofructokinase-1. Other methods that have been used also require auxiliary enzymes or are less sensitive than a coupled assay. Here, we propose a direct method to determine phosphofructokinase-1 activity, without the use of auxiliary enzymes. This method employs fructose-6-phosphate and ATP labeled with 32P in the gamma position ([gamma-32P]ATP), and leads to the formation of ADP and fructose-1,6-bisphosphate labeled with 32P ([1-32P]fructose-1,6-bisphosphate). Activated charcoal is used to adsorb unreacted [gamma-32P]ATP, and the radioactive product in the supernatant, [1-32P]fructose-1,6-bisphosphate, is analyzed on a liquid scintillation counter. The proposed method is precise and relatively inexpensive, and can be applied to determine phosphofructokinase-1 activity in cellular extracts as well as in the purified enzyme.
Asunto(s)
Fosfofructoquinasa-1/análisis , Adenosina Trifosfato , Animales , Chlorocebus aethiops , Eritrocitos/enzimología , Fructosafosfatos , Humanos , Cinética , Músculo Esquelético/enzimología , Fosfofructoquinasa-1/sangre , Fosfofructoquinasa-1/aislamiento & purificación , Fosfofructoquinasa-1 Tipo Muscular/análisis , Fosfofructoquinasa-1 Tipo Muscular/aislamiento & purificación , Radioisótopos de Fósforo , Conejos , Radiometría/métodos , Conteo por Cintilación , Espectrofotometría/métodos , Especificidad por Sustrato , Células VeroRESUMEN
We report a 2-year-old boy with phosphofructokinase deficiency presenting in the newborn period with congenital arthrogryposis and severe myopathy, who has had significant improvement on a ketogenic diet since its institution at 4 months of age. We provide a rationale for use of this treatment and hypothesize it may be beneficial in other patients with phosphofructokinase deficiency and progressive muscular involvement. Confirmation awaits further clinical trials in carefully selected patients.
Asunto(s)
Artrogriposis/dietoterapia , Fosfofructoquinasa-1/deficiencia , Artrogriposis/orina , Biopsia , Grasas de la Dieta/administración & dosificación , Electromiografía , Humanos , Recién Nacido , Masculino , Músculo Esquelético/química , Músculo Esquelético/patología , Músculo Esquelético/fisiopatología , Fosfofructoquinasa-1/análisis , Resultado del TratamientoRESUMEN
Phosphofructokinase (PFK) from human polymorphonuclear leukocytes (PMN) was characterized by immunological titration with subunit specific antibodies, column chromatography on QAE-Sephadex and SDS-polyacrylamide gel electrophoresis. Two different isozymes, M-type and L-type, were found. The M(r) values of the M and L subunits were 79,500 +/- 1,914 and 74,250 +/- 1,258, respectively. The two isozymes presented different kinetic and regulatory properties. The results suggest that PFK from human normal PMN is a mixture of M-type and L-type homotetramers, mainly, with possible minor heterotetrameric forms.
Asunto(s)
Isoenzimas/análisis , Neutrófilos/enzimología , Fosfofructoquinasa-1/análisis , Adenosina Trifosfato/metabolismo , Adenosina Trifosfato/farmacología , Cromatografía por Intercambio Iónico , Citratos/farmacología , Ácido Cítrico , Electroforesis en Gel de Poliacrilamida , Activación Enzimática/efectos de los fármacos , Inhibidores Enzimáticos/farmacología , Fructosadifosfatos/farmacología , Humanos , Técnicas de Inmunoadsorción , Isoenzimas/antagonistas & inhibidores , Isoenzimas/metabolismo , Cinética , Sustancias Macromoleculares , Fosfofructoquinasa-1/antagonistas & inhibidores , Fosfofructoquinasa-1/metabolismoRESUMEN
Se presentan los resultados de la actividad de la aldolasa, gliceraldehído-3 fosfato deshidrogenasa (GAPDH) y de la fosfofructokinasa (PKG) en membranas de drepanocitos. Se encontró una disminución de un 45 de la actividad de la GAPDH en drepanocitos irreversibles. Se plantea como una explicación probable, la competencia entre la GAPDH y la Hb S para el mismo sitio de fijación en la banda 3 de las membranas de las DI (AU)